Authors: KNAPP MA

Citation: Ma. Knapp, NOTE FDA REGULATIONS ON PSA ASSAYS, Laboratory medicine, 27(4), 1996, pp. 214-214

Authors: WALEH NS BRODY MD KNAPP MA MENDONCA HL LORD EM KOCH CJ LADEROUTE KR SUTHERLAND RM

Citation: Ns. Waleh et al., MAPPING OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR-PRODUCING HYPOXIC CELLS IN MULTICELLULAR TUMOR SPHEROIDS USING A HYPOXIA-SPECIFIC MARKER, Cancer research, 55(24), 1995, pp. 6222-6226

Authors: FONTANA RJ TURGEON DK WOOLF TF KNAPP MA WATKINS PB

Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF CAFFEINE TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Hepatology, 19(4), 1994, pp. 90000063-90000063

Authors: MANSBRIDGE JN AUSSERER WA KNAPP MA SUTHERLAND RM

Citation: Jn. Mansbridge et al., ADAPTATION OF EGF RECEPTOR SIGNAL-TRANSDUCTION TO 3-DIMENSIONAL CULTURE CONDITIONS - CHANGES IN SURFACE-RECEPTOR EXPRESSION AND PROTEIN-TYROSINE PHOSPHORYLATION, Journal of cellular physiology, 161(2), 1994, pp. 374-382

Authors: FONTANA RJ TURGEON DK WOOLF TF KNAPP MA WATKINS PB

Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF METABOLIC PROBES TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Gastroenterology, 106(4), 1994, pp. 10000893-10000893

Authors: MCALEESE KA KNAPP MA RHODES TT

Citation: Ka. Mcaleese et al., FINANCIAL AND EMOTIONAL COST OF BRONCHOPULMONARY DYSPLASIA, Clinical pediatrics, 32(7), 1993, pp. 393-400